UBS AM’s Globus Medical GMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $19.8M | Sell |
250,823
-6,715
| -3% | -$571K | ﹤0.01% | 946 |
|
|
2026
Q1 | $22.2M | Buy |
257,538
+12,843
| +5% | +$1.15M | ﹤0.01% | 844 |
|
|
2025
Q4 | $21.4M | Sell |
244,695
-6,832
| -3% | -$519K | ﹤0.01% | 826 |
|
|
2025
Q3 | $14.4M | Sell |
251,527
-229,545
| -48% | -$13.2M | ﹤0.01% | 950 |
|
|
2025
Q2 | $28.4M | Buy |
481,072
+133,545
| +38% | +$8.63M | 0.01% | 905 |
|
|
2025
Q1 | $25.4M | Buy |
347,527
+28,027
| +9% | +$2.32M | 0.01% | 860 |
|
|
2024
Q4 | $26.4M | Buy |
319,500
+28,330
| +10% | +$2.23M | 0.01% | 845 |
|
|
2024
Q3 | $20.8M | Buy |
291,170
+3,584
| +1% | +$253K | 0.01% | 935 |
|
|
2024
Q2 | $19.7M | Buy |
287,586
+117,352
| +69% | +$7.01M | 0.01% | 868 |
|
|
2024
Q1 | $9.13M | Sell |
170,234
-3,942
| -2% | -$212K | ﹤0.01% | 1036 |
|
|
2023
Q4 | $9.28M | Sell |
174,176
-7,814
| -4% | -$381K | ﹤0.01% | 1013 |
|
|
2023
Q3 | $9.04M | Buy |
181,990
+68,513
| +60% | +$3.83M | ﹤0.01% | 990 |
|
|
2023
Q2 | $6.43M | Hold |
113,477
| – | – | ﹤0.01% | 1127 |
|
|
2023
Q1 | $6.43M | Sell |
113,477
-7,450
| -6% | -$478K | ﹤0.01% | 1127 |
|
|
2022
Q4 | $8.98M | Buy |
120,927
+3,934
| +3% | +$268K | ﹤0.01% | 980 |
|
|
2022
Q3 | $6.97M | Sell |
116,993
-26,398
| -18% | -$1.59M | ﹤0.01% | 1088 |
|
|
2022
Q2 | $8.05M | Buy |
143,391
+17,582
| +14% | +$1.16M | ﹤0.01% | 1049 |
|
|
2022
Q1 | $9.28M | Sell |
125,809
-7,170
| -5% | -$498K | ﹤0.01% | 1097 |
|
|
2021
Q4 | $9.6M | Sell |
132,979
-231
| -0.2% | -$16.8K | ﹤0.01% | 1143 |
|
|
2021
Q3 | $10.2M | Sell |
133,210
-3,191
| -2% | -$256K | ﹤0.01% | 1089 |
|
|
2021
Q2 | $10.6M | Buy |
136,401
+6,437
| +5% | +$458K | ﹤0.01% | 1101 |
|
|
2021
Q1 | $8.01M | Sell |
129,964
-7,876
| -6% | -$499K | ﹤0.01% | 1152 |
|
|
2020
Q4 | $8.99M | Buy |
137,840
+9,651
| +8% | +$555K | ﹤0.01% | 1096 |
|
|
2020
Q3 | $6.35M | Buy |
128,189
+9,418
| +8% | +$486K | ﹤0.01% | 1074 |
|
|
2020
Q2 | $5.67M | Sell |
118,771
-9,887
| -8% | -$477K | ﹤0.01% | 1070 |
|
|
2020
Q1 | $5.47M | Sell |
128,658
-4,302
| -3% | -$213K | ﹤0.01% | 1025 |
|
|
2019
Q4 | $7.83M | Sell |
132,960
-23,938
| -15% | -$1.3M | ﹤0.01% | 1032 |
|
|
2019
Q3 | $8.02M | Buy |
156,898
+10,138
| +7% | +$483K | 0.01% | 1037 |
|
|
2019
Q2 | $6.21M | Sell |
146,760
-70,991
| -33% | -$3.08M | ﹤0.01% | 1120 |
|
|
2019
Q1 | $10.8M | Buy |
217,751
+2,239
| +1% | +$101K | 0.01% | 911 |
|
|
2018
Q4 | $9.33M | Sell |
215,512
-2,830
| -1% | -$141K | 0.01% | 897 |
|
|
2018
Q3 | $12.4M | Sell |
218,342
-362
| -0.2% | -$19.1K | 0.01% | 877 |
|
|
2018
Q2 | $11M | Sell |
218,704
-2,989
| -1% | -$156K | 0.01% | 924 |
|
|
2018
Q1 | $11M | Sell |
221,693
-642
| -0.3% | -$30.2K | 0.01% | 912 |
|
|
2017
Q4 | $9.14M | Buy |
222,335
+15,844
| +8% | +$555K | 0.01% | 940 |
|
|
2017
Q3 | $6.14M | Sell |
206,491
-165
| -0.1% | -$5.04K | 0.01% | 1019 |
|
|
2017
Q2 | $6.85M | Buy |
206,656
+5,021
| +2% | +$158K | 0.01% | 964 |
|
|
2017
Q1 | $5.97M | Buy |
201,635
+46,857
| +30% | +$1.28M | 0.01% | 989 |
|
|
2016
Q4 | $3.84M | Buy |
154,778
+30,756
| +25% | +$699K | ﹤0.01% | 1052 |
|
|
2016
Q3 | $2.8M | Buy |
124,022
+16,430
| +15% | +$386K | ﹤0.01% | 1252 |
|
|
2016
Q2 | $2.56M | Sell |
107,592
-2,925
| -3% | -$70.2K | ﹤0.01% | 1265 |
|
|
2016
Q1 | $2.63M | Buy |
110,517
+19,836
| +22% | +$485K | ﹤0.01% | 1248 |
|
|
2015
Q4 | $2.52M | Buy |
90,681
+46,820
| +107% | +$1.18M | ﹤0.01% | 1336 |
|
|
2015
Q3 | $906K | Buy |
43,861
+10,300
| +31% | +$261K | ﹤0.01% | 1762 |
|
|
2015
Q2 | $862K | Buy |
33,561
+12,261
| +58% | +$310K | ﹤0.01% | 1750 |
|
|
2015
Q1 | $538K | Buy |
21,300
+900
| +4% | +$21.9K | ﹤0.01% | 1941 |
|
|
2014
Q4 | $485K | Buy |
20,400
+1,700
| +9% | +$37.6K | ﹤0.01% | 1960 |
|
|
2014
Q3 | $368K | Hold |
18,700
| – | – | ﹤0.01% | 2029 |
|
|
2014
Q2 | $447K | Buy |
18,700
+1,100
| +6% | +$26.5K | ﹤0.01% | 1956 |
|
|
2014
Q1 | $468K | Buy |
17,600
+100
| +0.6% | +$2.38K | ﹤0.01% | 1936 |
|
|
2013
Q4 | $353K | Buy |
17,500
+1,200
| +7% | +$22.3K | ﹤0.01% | 2017 |
|
|
2013
Q3 | $285K | Hold |
16,300
| – | – | ﹤0.01% | 2117 |
|
|
2013
Q2 | $275K | Buy |
+16,300
| New | +$252K | ﹤0.01% | 2044 |
|
Other funds holding GMED
JT
SC
UBS AM's GMED Position: Q2 2026 in Review
UBS AM reduced its Globus Medical (GMED) stake by 2.6% in Q2 2026, selling an estimated $571K and leaving 250,823 shares worth $19.8M. The position accounts for ﹤0.01% of the portfolio, ranked #946.
UBS AM first reported a position in GMED in Q2 2013 and has held it in 53 quarters since. The position peaked at $28.4M in Q2 2025. 594 funds tracked by Wall St. Rank hold GMED as of Q2 2026.
- UBS AM held 250,823 shares of Globus Medical worth $19.8M as of Q2 2026.
- UBS AM sold 6,715 Globus Medical shares in Q2 2026, an estimated $571K.
- Globus Medical made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #946 holding.
- UBS AM first reported a position in Globus Medical in Q2 2013 and has held it in 53 quarters since.
- UBS AM's Globus Medical position peaked at $28.4M in Q2 2025.
- 594 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.
Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.